Free Trial

Feedback (FDBK) Competitors

Feedback logo
GBX 19.50 0.00 (0.00%)
(As of 12/4/2024 ET)

FDBK vs. INHC, IQAI, DVRG, TRLS, SENS, EMIS, CRW, INS, KOO, and COG

Should you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Cambridge Cognition (COG). These companies are all part of the "health information services" industry.

Feedback vs.

Feedback (LON:FDBK) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, community ranking, valuation, risk, media sentiment and analyst recommendations.

Feedback has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Induction Healthcare Group has a beta of -0.41, suggesting that its share price is 141% less volatile than the S&P 500.

Feedback received 151 more outperform votes than Induction Healthcare Group when rated by MarketBeat users. However, 93.33% of users gave Induction Healthcare Group an outperform vote while only 67.07% of users gave Feedback an outperform vote.

CompanyUnderperformOutperform
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%
Induction Healthcare GroupOutperform Votes
14
93.33%
Underperform Votes
1
6.67%

In the previous week, Feedback had 2 more articles in the media than Induction Healthcare Group. MarketBeat recorded 3 mentions for Feedback and 1 mentions for Induction Healthcare Group. Induction Healthcare Group's average media sentiment score of 1.62 beat Feedback's score of -0.10 indicating that Induction Healthcare Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Feedback
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Induction Healthcare Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

53.2% of Feedback shares are held by institutional investors. Comparatively, 46.3% of Induction Healthcare Group shares are held by institutional investors. 10.8% of Feedback shares are held by company insiders. Comparatively, 54.6% of Induction Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Induction Healthcare Group has higher revenue and earnings than Feedback. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£1.18M2.20-£3.30M-£0.25-78.00
Induction Healthcare Group£13.65M0.62-£3.25M-£0.03-300.00

Induction Healthcare Group has a net margin of -23.86% compared to Feedback's net margin of -279.16%. Induction Healthcare Group's return on equity of -14.53% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-279.16% -35.63% -22.99%
Induction Healthcare Group -23.86%-14.53%-7.32%

Summary

Induction Healthcare Group beats Feedback on 9 of the 15 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

MetricFeedbackHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£2.60M£235.14M£5.21B£1.38B
Dividend Yield4.56%6.58%5.38%11.77%
P/E Ratio-78.00780.81119.271,511.49
Price / Sales2.20296.281,305.34381,194.92
Price / Cash1.1238.9042.3134.14
Price / Book0.344.774.892.95
Net Income-£3.30M-£5.84M£119.35M£128.31M
7 Day Performance-1.27%2.88%3.24%0.64%
1 Month Performance-20.41%6.80%3.31%-0.03%
1 Year Performance-72.92%8.15%32.85%105.51%

Feedback Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 19.50
flat
N/A-72.9%£2.60M£1.18M-78.0024Insider Trade
News Coverage
INHC
Induction Healthcare Group
N/AGBX 9.65
+7.2%
N/A-63.2%£9.06M£13.65M-321.6774Positive News
Gap Up
High Trading Volume
IQAI
IQ-AI
N/AGBX 1.42
-3.7%
N/A-60.8%£3.16M£538,190.00-13.676
DVRG
DeepVerge
N/AGBX 0.15
flat
N/AN/A£1.14M£12.41M-15.0073
TRLS
Trellus Health
N/AGBX 0.60
-1.0%
N/A-84.0%£969,000.00£35,000.00-20.0031
SENS
Sensyne Health
N/AGBX 0.35
-33.3%
N/A+0.0%£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AGBX 1,920
flat
N/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
N/AGBX 2,345
-1.5%
GBX 2,700
+15.1%
+42.4%£828.72M£189.27M9,269.23734
INS
Instem
N/AGBX 830
flat
N/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
N/AGBX 177.80
-0.1%
GBX 585
+229.0%
N/A£64.86M£54.17M1,481.67478
COG
Cambridge Cognition
N/AGBX 27.89
+2.1%
N/A-49.9%£11.70M£13.08M-687.5080

Related Companies and Tools


This page (LON:FDBK) was last updated on 12/4/2024 by MarketBeat.com Staff
From Our Partners